Crossmark

Early linear growth retardation: results of a prospective study of Zambian infants

Crossref DOI link: https://doi.org/10.1186/s12889-019-6411-3

Published Online: 2019-01-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chilengi, Roma

Asombang, Mah

Kadota, Jillian L.

Chilyabanyama, Obvious N.

Mwila-Kazimbaya, Katayi

Ng’ombe, Harriet

Simuyandi, Michelo

Bosomprah, Samuel https://orcid.org/0000-0003-4473-0163
License Information

Text and Data Mining valid from 2019-01-14
More Information

Article History

Received: 31 July 2018

Accepted: 7 January 2019

First Online: 14 January 2019

Ethics approval and consent to participate

: The University of Zambia Biomedical Research Ethics Committee, University of North Carolina at Chapel Hill Institutional Review Board and the Zambian Ministry of Health approved the study. The study was conducted in accordance with the principles of the Declaration of Helsinki and in compliance with good clinical practice guidelines and is registered at ClinicalTrials.gov with registration number NCT01886833. Written informed consent was obtained from all mothers of participating infants.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.